Abstract
Methodology of the synthesis of higher carbon sugars containing > 10 carbon atoms in the chain is reviewed. The emphasis is put on such derivatives which can be (or are) easily converted into higher alditols.
Keywords: Higher carbon sugars, higher alditols, stereoselective synthesis, natural products.
Current Organic Chemistry
Title:A Review on the Stereoselective Synthesis of Higher Carbon Sugars with an Eye to Making Higher Alditols
Volume: 18 Issue: 3
Author(s): Anna Osuch-Kwiatkowska, Maciej Cieplak and Slawomir Jarosz
Affiliation:
Keywords: Higher carbon sugars, higher alditols, stereoselective synthesis, natural products.
Abstract: Methodology of the synthesis of higher carbon sugars containing > 10 carbon atoms in the chain is reviewed. The emphasis is put on such derivatives which can be (or are) easily converted into higher alditols.
Export Options
About this article
Cite this article as:
Osuch-Kwiatkowska Anna, Cieplak Maciej and Jarosz Slawomir, A Review on the Stereoselective Synthesis of Higher Carbon Sugars with an Eye to Making Higher Alditols, Current Organic Chemistry 2014; 18 (3) . https://dx.doi.org/10.2174/138527281803140228113441
DOI https://dx.doi.org/10.2174/138527281803140228113441 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Physiological Functions of NO-Sensitive Guanylyl Cyclase Isoforms
Current Medicinal Chemistry Statins in the Prevention of Cardiovascular Events in Patients with Renal Failure
Cardiovascular & Hematological Disorders-Drug Targets microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Current Pharmaceutical Design Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design Heart Failure in Sub-Saharan Africa
Current Cardiology Reviews A Historical Overview on Coronary Surgery and Interventional Cardiology: Parallel Pathways?
Vascular Disease Prevention (Discontinued) Bidirectional Nature of Cardiovascular and Kidney Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Thyroid Hormone Antagonists: Potential Medical Applications and Structure Activity Relationships
Current Medicinal Chemistry Impact of Anabolic Androgenic Steroids on Neuropeptide Systems
Mini-Reviews in Medicinal Chemistry Computational Modeling and Simulation of the Bcl-2 Family: Paving the Way for Rational Drug Design
Current Medicinal Chemistry Disorders of Innate Immunity in Human ageing and effects of Nutraceutical Administration
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical and Prognostic Implications of Cognitive Dysfunction and Depression in COPD
Current Respiratory Medicine Reviews An Overview on Functional and Structural Properties of Monomeric and Multimeric β-Thymosin in Invertebrates
Protein & Peptide Letters Neonatal Ultrasound in Transport
Current Pediatric Reviews Bariatric Surgery: Indications, Safety and Efficacy
Current Pharmaceutical Design What Characterizes Endothelial Dysfunction in Preeclampsia? -The Action of NO and the Production of Prostacyclin is Reduced, While EDHF is Preserved in Omental Resistance Arteries in Preeclamptic Women
Current Women`s Health Reviews Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
CNS & Neurological Disorders - Drug Targets Positive Social Interactions in a Lifespan Perspective with a Focus on Opioidergic and Oxytocinergic Systems: Implications for Neuroprotection
Current Neuropharmacology Current Problems with Non-Specific COX Inhibitors
Current Pharmaceutical Design Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism